National Bank of Canada’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-452
| Closed | -$50K | – | 2736 |
|
|
2025
Q1 | $50K | Sell |
452
-5
| -1% | -$553 | ﹤0.01% | 1579 |
|
|
2024
Q4 | $62.5K | Sell |
457
-894
| -66% | -$122K | ﹤0.01% | 1523 |
|
|
2024
Q3 | $156K | Buy |
1,351
+614
| +83% | +$70.7K | ﹤0.01% | 1267 |
|
|
2024
Q2 | $103K | Buy |
737
+15
| +2% | +$2.1K | ﹤0.01% | 1336 |
|
|
2024
Q1 | $98.7K | Sell |
722
-22,244
| -97% | -$3.04M | ﹤0.01% | 1375 |
|
|
2023
Q4 | $3.03M | Buy |
22,966
+21,964
| +2,192% | +$2.89M | ﹤0.01% | 797 |
|
|
2023
Q3 | $111K | Sell |
1,002
-52
| -5% | -$5.78K | ﹤0.01% | 1400 |
|
|
2023
Q2 | $99.3K | Sell |
1,054
-65,673
| -98% | -$6.19M | ﹤0.01% | 1443 |
|
|
2023
Q1 | $6.75M | Buy |
66,727
+55,598
| +500% | +$5.62M | 0.02% | 453 |
|
|
2022
Q4 | $1.33M | Buy |
11,129
+9,985
| +873% | +$1.19M | ﹤0.01% | 901 |
|
|
2022
Q3 | $129K | Sell |
1,144
-150
| -12% | -$16.9K | ﹤0.01% | 1317 |
|
|
2022
Q2 | $126K | Buy |
1,294
+31
| +2% | +$3.02K | ﹤0.01% | 1326 |
|
|
2022
Q1 | $118K | Buy |
1,263
+34
| +3% | +$3.18K | ﹤0.01% | 1399 |
|
|
2021
Q4 | $105K | Buy |
+1,229
| New | +$105K | ﹤0.01% | 1418 |
|